Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase

L. Pilotte, P. Larrieu, V. Stroobant, D. Colau, E. Dolušić, R. Frédérick, E. De Plaen, C. Uyttenhove, J. Wouters, B. Masereel, B.J. Van Den Eynde

Research output: Contribution to journalArticle

55 Downloads (Pure)

Abstract

Tryptophan catabolism mediated by indoleamine 2,3-dioxygenase (IDO1) is an important mechanism of peripheral immune tolerance contributing to tumoral immune resistance, and IDO1 inhibition is an active area of drug development. Tryptophan 2,3-dioxygenase (TDO) is an unrelated hepatic enzyme that also degrades tryptophan along the kynurenine pathway. Here, we show that enzymatically active TDO is expressed in a significant proportion of human tumors. In a preclinical model, TDO expression by tumors prevented their rejection by immunized mice. We developed a TDO inhibitor, which, upon systemic treatment, restored the ability of mice to reject TDO-expressing tumors. Our results describe a mechanism of tumoral immune resistance based on TDO expression and establish proof-of-concept for the use of TDO inhibitors in cancer therapy.
Original languageEnglish
Pages (from-to)2497-2502
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume109
Issue number7
DOIs
Publication statusPublished - 14 Feb 2012

Fingerprint Dive into the research topics of 'Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase'. Together they form a unique fingerprint.

  • Projects

    Equipment

  • Activities

    • 5 Participation in conference

    Heterocycles in Bio-organic Chemistry

    Eduard Dolusic (Poster)

    27 May 2013

    Activity: Participating in or organising an event typesParticipation in conference

    BOSS XIII - 13th Belgian Organic Synthesis Symposium Louvain, 15 - 20 juillet 2012

    Eduard Dolusic (Poster)

    15 Jul 2012

    Activity: Participating in or organising an event typesParticipation in conference

    Annual One-Day Meeting on Medicinal Chemistry of SRC & KVCV (Medchem 2011)

    Eduard Dolusic (Poster)

    25 Nov 2011

    Activity: Participating in or organising an event typesParticipation in conference

    Press / Media

    Mladi Ogulinac u ekipi koja je na tragu lijeka protiv raka

    Eduard Dolusic

    24/02/12

    1 item of Media coverage

    Press/Media: Other

    USPJEH MLADOGA OGULINCA

    Eduard Dolusic

    24/02/12

    1 item of Media coverage

    Press/Media: Other

    Ogulinac Eduard Dolušić nadomak otkriću lijeka protiv raka

    Eduard Dolusic

    23/02/12

    1 item of Media coverage

    Press/Media: Other

    Cite this